Back to NewsPublished: 30 Dec 2025Download AppJoin TelegramLupin Wins Exclusive Indian Rights to Fortnightly Bofanglutide, Aiming at Diabetes & Obesity#Lupin#Bofanglutide#GLP-1#Diabetes#ObesityDownload AppJoin CommunityShare Article